These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 38179745)

  • 1. Lipid Peroxidation in Ferroptosis and Association with Nonalcoholic Fatty Liver Disease.
    Zhao S; Guo Y; Yin X
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):332. PubMed ID: 38179745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease.
    Sui Y; Geng X; Wang Z; Zhang J; Yang Y; Meng Z
    Metabolism; 2024 Aug; 157():155953. PubMed ID: 38885833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.
    Gao G; Xie Z; Li EW; Yuan Y; Fu Y; Wang P; Zhang X; Qiao Y; Xu J; Hölscher C; Wang H; Zhang Z
    J Nat Med; 2021 Jun; 75(3):540-552. PubMed ID: 33590347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies.
    Zhang H; Zhang E; Hu H
    Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin targets ferroptosis through bimodal alteration of redox environment and cellular pathways in NAFLD model.
    Saha M; Das S; Manna K; Saha KD
    Biosci Rep; 2023 Oct; 43(10):. PubMed ID: 37728565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of ferroptosis in nonalcoholic fatty liver disease and therapeutic effects of traditional Chinese medicine: a review.
    Wang N; Que H; Luo Q; Zheng W; Li H; Wang Q; Gu J
    Front Med (Lausanne); 2024; 11():1356225. PubMed ID: 38590315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research progress on the mechanism of action of heme oxygenase-1 regulating ferroptosis in non-alcoholic fatty liver disease].
    Yuan XW; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2024 Mar; 32(3):262-267. PubMed ID: 38584112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron metabolism and ferroptosis in nonalcoholic fatty liver disease: what is our next step?
    Shen X; Yu Z; Wei C; Hu C; Chen J
    Am J Physiol Endocrinol Metab; 2024 Jun; 326(6):E767-E775. PubMed ID: 38506752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis in non-alcoholic liver disease: Molecular mechanisms and therapeutic implications.
    Cheng Z; Chu H; Zhu Q; Yang L
    Front Nutr; 2023; 10():1090338. PubMed ID: 36992907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of ferroptosis in non-alcoholic fatty liver disease.
    Wang S; Liu Z; Geng J; Li L; Feng X
    Biomed Pharmacother; 2022 Sep; 153():113374. PubMed ID: 35834990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FMO1 Promotes Nonalcoholic Fatty Liver Disease Progression by Regulating PPARα Activation and Inducing Ferroptosis.
    Zou L; Shi Q; Li Y; Yuan Z; Peng L; Lu J; Zhu H; Ma J
    Discov Med; 2023 Aug; 35(177):612-622. PubMed ID: 37553313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration and Validation of Ferroptosis-Associated Genes in ADAR1 Deletion-Induced NAFLD through RNA-seq Analysis.
    Yin X; Mi Y; Wang X; Li Y; Zhu X; Bukhari I; Wang Q; Zheng P; Xue X; Tang Y
    Int Immunopharmacol; 2024 Jun; 134():112177. PubMed ID: 38696908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin improves nonalcoholic fatty liver disease in db/db mice by inhibiting ferroptosis.
    Zhang T; Wang MY; Wang GD; Lv QY; Huang YQ; Zhang P; Wang W; Zhang Y; Bai YP; Guo LQ
    Eur J Pharmacol; 2024 Mar; 966():176341. PubMed ID: 38244761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unveiling the role of ferroptosis in the progression from NAFLD to NASH: recent advances in mechanistic understanding.
    Yu Q; Song L
    Front Endocrinol (Lausanne); 2024; 15():1431652. PubMed ID: 39036052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?
    Feng G; Byrne CD; Targher G; Wang F; Zheng MH
    Liver Int; 2022 Jul; 42(7):1496-1502. PubMed ID: 35007392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis.
    Rochette L; Dogon G; Rigal E; Zeller M; Cottin Y; Vergely C
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis resistance cooperates with cellular senescence in the overt stage of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Vetuschi A; Cappariello A; Onori P; Gaudio E; Latella G; Pompili S; Sferra R
    Eur J Histochem; 2022 Jun; 66(3):. PubMed ID: 35726536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease.
    Yang Y; Chen J; Gao Q; Shan X; Wang J; Lv Z
    Toxicology; 2020 Dec; 445():152599. PubMed ID: 32976958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Gut Microbiome and Ferroptosis in MAFLD.
    Ji J; Wu L; Wei J; Wu J; Guo C
    J Clin Transl Hepatol; 2023 Feb; 11(1):174-187. PubMed ID: 36406312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Mitochondrial ROS-Mediated Ferroptosis by Quercetin Alleviates High-Fat Diet-Induced Hepatic Lipotoxicity.
    Jiang JJ; Zhang GF; Zheng JY; Sun JH; Ding SB
    Front Pharmacol; 2022; 13():876550. PubMed ID: 35496312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.